- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02692560
I-STAND R21: Reducing Sedentary Time in Older Adults
Take Active Breaks From Sitting (TABS): Reducing Sedentary Time in Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
More than one-third of American adults over 60 have a body mass index > 30 kg/m2. These older adults have more sedentary time than any other group -- an average of 10-11 hours per day. Reducing the sedentary behavior of older adults with obesity, rather than only promoting more intensive physical activity, could provide a more feasible approach to health promotion.
This randomized control pilot trial will evaluate a 12-week intervention to decrease sitting time and increase standing time and light physical activity among sedentary older adults a body mass index > 30 kg/m2 as compared to control group. Baseline and 12-week measurements include anthropometric measures, blood draw by finger stick, cardiovascular health assessments, physical function tasks, and a survey. The intervention will consist of two in-person visits with a health coach followed by phone-based coaching.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Kaiser Permanente Washington Health Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Kaiser Permanente Washington enrollees
- Men and women
- Age 60 - 89
- BMI 30 - 50 (calculated based on most recent height ever and most recent weight taken within previous 18 months)
- Primary care within Integrated Group Practice
- Continuously enrolled at Kaiser Permanente Washington for previous 12 months
- No record of death
- Not on the No Contact list
- Speaks and writes English
- Able to hold a conversation by phone (no hearing or other limitations)
- Self-reported sitting time of 6 hours/day or more
- Self-reported ability to stand with or without an assistive device
- Self-reported ability to walk one block with or without an assistive device
- Available for the study duration
- Able to come to Kaiser Permanente Washington Health Research Institute's research clinic for measurement visits
- Willing to wear study activity monitors
Exclusion Criteria:
- Resides in long-term care, hospice care, or skilled nursing facility (previous 12 months)
- Wheelchair bound
- Diagnosis of dementia, serious mental health disorder, or substance use disorder (previous 24 months)
- Use of an assistive device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: I-STAND
Participants randomly assigned to the I-STAND intervention group will receive 2 in-person health coaching sessions and 4 biweekly phone-based health coaching sessions.
They will receive a wristband that gives a mild vibration after 20 minutes of inactivity and will be encouraged to stand if possible after each inactivity alert.
Participants may also choose to receive biweekly email reminders in the weeks between coaching calls.
They will also receive a workbook with content around reducing sitting time.
|
Participants receive health coaching, a workbook, an inactivity alert wristband, and feedback charts based on objective measurement of sedentary time.
|
|
Active Comparator: Healthy Living
Participants randomly assigned to the Healthy Living enhanced usual care control group will receive 1 in-person health coaching session and 5 biweekly check-in letters by mail.
They will receive a workbook with general healthy living topics that are not expected to impact sitting time.
All content is taken from Kaiser Permanente Washington's website and is available to all members.
Participants will select topics of interest and review them on their own with no further health coaching.
|
Participants receive enhanced usual care based on general healthy living topics that are available to all Kaiser Permanente Washington enrollees.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hours of Sitting Time
Time Frame: 12 weeks
|
Average hours of sitting time over the last 7 days measured at baseline and 12 weeks later
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sit-to-stand Transitions
Time Frame: 12 weeks
|
Change in average daily number of activPAL-measured sit-to-stand transitions, from baseline to 12 weeks
|
12 weeks
|
|
Periods of Sitting for 30+ Minutes
Time Frame: 12 weeks
|
Change in average daily number of activPAL-measured periods of sitting for 30+ minutes without standing, from baseline to 12 weeks
|
12 weeks
|
|
Physical Function
Time Frame: 12 weeks
|
Change in Short Physical Performance Battery (SPPB) scale score, from baseline to 12 weeks.
The range of scores is 0 to 12, higher values represent better physical function.
|
12 weeks
|
|
Blood Pressure (Systolic Blood Pressure)
Time Frame: 12 weeks
|
Change in average of second and third blood pressure reading (for systolic blood pressure), from baseline to 12 weeks
|
12 weeks
|
|
Fasting Glucose (mg/dL)
Time Frame: 12 weeks
|
Change in fasting glucose (mg/dL) from finger stick blood draw, from baseline to 12 weeks
|
12 weeks
|
|
Total Cholesterol (mg/dL)
Time Frame: 12 weeks
|
Change in total cholesterol (mg/dL) from finger stick blood draw, from baseline to 12 weeks
|
12 weeks
|
|
Depressive Symptoms
Time Frame: 12 weeks
|
Change in Patient Health Questionnaire (PHQ-8) scale score, from baseline to 12 weeks.
The scale range is 0 to 24 with higher scores representing higher depressive symptoms.
Scores of 10 or more are considered major depression.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Matson TE, Renz AD, Takemoto ML, McClure JB, Rosenberg DE. Acceptability of a sitting reduction intervention for older adults with obesity. BMC Public Health. 2018 Jun 7;18(1):706. doi: 10.1186/s12889-018-5616-1.
- Rosenberg DE, Lee AK, Anderson M, Renz A, Matson TE, Kerr J, Arterburn D, McClure JB. Reducing Sedentary Time for Obese Older Adults: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Feb 12;7(2):e23. doi: 10.2196/resprot.8883.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1R21AG043853 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on I-STAND
-
Kaiser PermanenteNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of MinnesotaMayo ClinicCompletedSit-Stand WorkstationsUnited States
-
University of LouisvilleRecruitingNeurogenic BowelUnited States
-
Arizona State UniversityNational Cancer Institute (NCI); University of Minnesota; University of Utah; University... and other collaboratorsRecruitingSedentary BehaviorUnited States
-
Hamilton Health Sciences CorporationOntario Ministry of Health and Long Term CareUnknownCerebrovascular AccidentCanada
-
Caitríona QuinnCompletedHeart Rate Response | OrthostasisIreland
-
Montclair State UniversityEnrolling by invitationOverweight and ObesityUnited States
-
Lisa GriffinRecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - UncontrolledUnited States
-
Riphah International UniversityCompletedCerebral PalsyPakistan